CNMC Merger Prohibition: Spain Blocks Curium/IRAB Acquisition

CNMC Merger Prohibition: Spain Blocks Curium/IRAB Acquisition

Broadly framed concerns

The CNMC focused on two markets linked to cancer detection tests where the parties’ activities overlap:

  • The supply of PSMA PET radiopharmaceuticals where the CNMC found the parties have combined market shares of…

Continue Reading